Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.7	58.1	0.0	0.0	0.0	0.0	0.3	0.0	16.0	35.2	0.0	0.0	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.1	17.9	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 52.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Group enriched"	"Detected in some"	5	"A549: 60.2;Hep G2: 60.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071145	Enhanced					NA	NA					"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	60.2	0.9	3.0	4.6	3.5	1.0	0.1	0.3	0.1	0.2	12.9	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	60.0	0.1	0.0	0.2	0.6	4.1	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	11.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.4	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0.0	0.0	4.9	1.0	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.1	0.0	0.2	0.4	2.5	4.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.1	52.9	0.2	0.0	0.0	0.6	1.3	0.2	0.3	0.0	5.0	0.0	0.0	0.2	0.1	0.0	0.0	9.1	1.4	0.0	0.4	0.7	0.3	0.0	1.4	0.0	0.0	0.0
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"A549: 31.4;CAPAN-2: 24.0;OE19: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.2	31.4	0.0	0.1	1.8	2.8	0.0	4.2	5.2	0.3	0.3	1.7	24.0	0.0	3.3	8.2	5.9	5.7	0.0	0.4	0.4	0.0	0.0	0.6	13.2	9.5	7.1	0.0	0.0	3.1	2.3	1.2	2.5	3.5	0.5	0.0	0.0	0.0	3.3	7.3	0.0	0.0	0.0	34.9	4.1	0.0	0.0	0.1	13.7	13.6	0.0	0.2	7.6	1.3	0.0	0.0	1.0	0.0	6.9	0.2	1.4	0.1	3.3	0.0	0.0	0.0	3.4	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0	17.9	5.6	2.4	103.4	8.4	1.2	2.5	262.4	0.0	23.9	14.0	0.0	0.3	5.0	84.3	55.0	1.4	161.4	0.0	92.3	3.0	3.5	62.4	0.0	155.5	27.5	1.6	22.7	4.9	18.2	59.8	8.3	13.8	3.3	4.6	85.5	3.7	82.4	153.0	2.8	7.9	0.1	0.0	5.2	0.7	0.6	9.3	0.8	2.5	66.2	81.6
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2"	"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.5	8.0	1.3	2.4	2.5	3.3	0.3	3.6	3.7	3.3	2.8	11.1	3.4	2.5	2.4	4.9	2.4	6.2	2.0	1.8	4.1	7.5	3.1	61.8	2.5	2.2	5.1	7.0	67.7	2.5	0.8	2.3	4.8	4.7	4.2	2.8	6.4	0.1	4.4	1.4	1.3	1.1	1.5	5.5	1.9	1.9	3.7	6.6	18.2	10.3	3.3	2.4	1.2	0.2	2.5	1.5	0.0	3.8	6.9	3.5	2.2	2.9	4.3	0.0	0.0	1.0	6.6	4.0	1.7	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0	8.9	28.3	3.7	6.2	3.8	0.0	3.1	5.1	6.7	11.4	22.7	21.6	0.1	0.0	5.2	3.2	11.3	1.4	0.0	2.6	0.4	3.9	38.5	53.1	0.0	3.8	0.0	0.0	2.5	1.0	1.7	6.4	6.3	1.7	19.0	3.2	0.3	4.1	9.3	1.8	32.7	0.7	0.0	3.9	0.6	9.1	6.6	0.2	2.2	7.8	3.7
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7"									"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.6	18.8	5.6	0.0	0.2	0.0	32.9	0.7	0.6	1.0	1.6	4.1	0.2	0.0	0.2	0.1	2.4	5.5	0.1	0.5	1.4	5.3	0.8	0.2	0.1	5.6	0.0	0.2	0.0	0.1	2.3	2.2	0.1	0.5	1.7	0.4	0.4	0.0	0.6	10.9	2.6	0.0	1.9	25.5	0.0	1.2	0.0	16.5	0.0	4.0	0.0	0.2	3.9	0.4	0.5	12.7	0.1	0.0	0.0	0.7	0.7	0.2	0.0	5.2	1.9	0.0	1.4	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5	3.0	1.4	0.5	0.2	3.4	0.0	1.1	0.0	1.4	0.0	0.0	0.0	14.3	1.7	0.0	2.6	9.0	135.7	0.0	0.2	47.1	2.1	0.2	5.7	25.0	105.8	0.0	2.9	13.5	1.0	0.4	1.1	1.1	5.0	0.0	2.9	0.9	0.1	35.1	0.4	4.5	0.2	0.0	1.4	0.9	3.4	0.4	31.5	0.8	0.8	0.1
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in all"	9	"Hepatocytes: 651.0;Proximal tubular cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 51.9;SK-BR-3: 82.5"					"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Supported	Peroxisomes		NA	NA		4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favorable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favorable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.1	8.9	3.0	9.5	13.1	7.7	10.6	7.5	10.9	8.6	8.2	11.9	9.2	4.8	5.4	12.0	4.2	5.4	8.2	12.7	4.7	7.0	8.5	6.2	7.9	33.7	8.5	14.3	14.0	14.2	9.1	7.4	5.3	5.4	11.6	11.8	5.8	5.7	9.5	10.6	13.8	10.2	3.2	51.9	10.8	3.1	5.8	8.1	24.2	24.2	2.6	4.1	7.3	82.5	5.2	4.4	8.5	11.5	8.4	5.2	5.0	10.4	10.3	7.6	4.8	3.8	8.5	12.5	8.3	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9	38.7	31.4	45.5	55.9	29.7	37.5	2.4	109.5	17.4	19.4	62.8	13.7	77.1	140.9	89.4	3.0	25.4	292.3	23.3	69.3	52.5	32.7	64.1	18.5	651.0	74.1	7.9	52.9	34.4	86.5	6.4	33.1	68.8	55.6	86.6	63.2	33.0	78.8	122.8	31.1	601.4	14.2	32.3	25.8	17.5	11.7	31.0	83.1	42.0	60.0	69.8
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria		NA	NA		19000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.5	32.1	13.2	18.1	57.0	21.0	25.0	24.7	34.4	28.1	17.5	12.9	30.3	18.0	20.6	51.7	10.1	25.9	8.8	27.0	24.9	56.9	9.1	9.6	22.8	19.7	27.4	9.1	25.0	23.3	24.7	23.5	37.1	43.6	25.3	22.1	12.3	21.9	45.1	12.7	9.4	11.0	6.2	35.2	12.7	13.2	14.6	42.6	62.6	30.6	3.5	8.7	34.8	44.3	20.2	12.9	20.3	14.0	25.1	24.9	18.7	12.6	24.1	20.6	9.6	0.9	45.9	16.1	18.1	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6	56.6	73.4	64.0	249.7	77.5	39.6	397.7	150.3	17.4	43.3	191.9	58.9	369.3	157.5	241.9	107.0	71.4	453.8	23.3	66.5	164.5	100.7	311.9	89.7	297.9	171.6	31.8	172.2	51.5	68.0	184.1	115.3	93.1	77.6	423.8	144.6	37.1	129.2	196.4	124.8	276.8	38.8	103.5	102.3	100.5	34.7	76.5	554.7	68.2	215.2	275.4
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 80.9;Late spermatids: 73.7;Muller glia cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 12.6;OE19: 17.6;RT4: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA041047: AB_2677273"	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.3	4.1	5.7	1.9	7.3	3.0	1.2	3.7	8.6	3.7	10.9	9.6	10.0	28.2	3.6	5.2	14.8	2.7	4.0	22.2	5.9	2.6	15.1	1.2	1.7	1.5	3.1	9.5	4.6	3.0	9.4	18.8	1.4	11.1	3.9	9.5	22.0	9.4	4.5	6.8	2.6	22.5	14.6	6.2	1.3	9.0	6.6	3.9	0.0	10.1	5.7	2.7	9.1	5.5	1.3	1.3	8.3	1.3	0.9	0.9	0.6	4.3	2.8	1.4	0.9	0.6	1.3	2.2	2.5	0.2	0.9	0.6	4.2	11.1	1.0	4.2	2.1	2.7	12.6	0.6	2.2	0.5	2.6	1.0	10.3	4.0	1.8	0.2	1.2	1.7	1.4	2.5	0.4	1.1	1.2	2.3	0.8	0.6	1.5	2.9	1.4	0.5	1.7	2.3	17.6	0.6	0.9	7.5	1.0	1.0	26.2	2.9	2.9	1.2	0.9	0.5	4.9	1.1	3.3	2.4	2.0	1.7	1.3	1.0	1.7	0.8	1.1	0.9	7.7	0.9	2.0	1.3	8.3	0.8	0.7	0.7	0.7	0.7	0.5	1.3	1.3	0.9	0.9	2.8	0.9	0.9	0.9	0.6	0.6	5.7	7.3	3.7	8.6	5.9	2.6	3.1	9.5	11.1	3.9	0.0	8.5	2.7	14.4	4.2	46.5	21.5	12.7	12.0	10.3	24.4	0.0	1.8	10.0	4.7	13.0	1.8	80.9	0.0	2.2	5.4	3.5	4.9	15.0	0.0	7.6	14.3	45.7	1.8	5.6	73.7	12.7	9.1	8.5	2.8	31.3	81.2	3.9	34.5	16.6	31.2	4.0	0.0	3.8	0.5	0.2	2.5	2.1	0.0	34.5	20.9
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.2	11.0	2.3	9.7	10.3	4.0	0.4	6.0	14.0	9.8	13.0	7.8	7.5	0.0	4.4	3.2	5.1	6.2	0.0	0.6	5.2	14.2	13.9	6.8	4.5	26.8	6.7	0.0	19.3	9.1	0.0	3.7	0.0	9.6	4.2	0.0	0.0	0.0	8.4	4.7	1.0	7.7	3.3	1.3	16.7	16.1	9.8	0.1	3.6	4.7	10.1	12.2	14.8	11.5	12.0	1.1	27.6	5.4	7.6	8.6	21.6	5.5	5.7	0.0	0.0	4.0	7.2	0.0	8.1	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7	0.0	5.4	1.7	1.0	1.4	0.9	43.0	7.6	4.0	1.2	7.0	9.8	4.6	11.6	18.3	1.0	3.6	16.2	0.0	29.2	2.3	3.9	0.3	13.8	25.8	13.9	1.6	15.1	3.7	4.0	0.4	5.5	2.0	5.0	30.7	15.1	3.3	19.0	5.8	7.8	16.5	4.5	6.5	4.2	0.4	4.3	0.4	6.9	5.7	19.7	0.4
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591706-73596496	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.6"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 22.2;Proximal tubular cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.3;MCF7: 5.6;SK-BR-3: 11.7;T-47d: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA					"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	6.3	2.2	2.9	1.4	3.6	0.6	4.4	1.6	5.7	3.6	2.6	1.0	1.5	3.9	1.0	2.4	2.0	0.9	3.3	2.9	2.1	2.0	13.0	15.6	3.9	1.1	1.6	2.8	0.9	2.2	1.1	0.7	4.9	2.7	1.4	3.1	1.8	3.1	3.4	0.7	0.9	7.4	2.5	0.8	1.4	1.9	2.8	0.9	0.3	1.2	0.8	1.2	1.1	1.3	1.7	0.6	5.0	0.4	4.6	10.6	3.2	4.3	1.2	0.1	0.0	0.5	0.2	0.0	0.3	0.0	0.3	0.5	0.1	7.3	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	1.6	0.0	0.8	0.0	4.1	0.3	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	5.6	0.1	0.8	0.4	1.5	1.2	0.0	0.0	0.0	0.1	2.1	0.6	0.2	2.8	11.7	0.8	0.0	29.2	4.4	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	1.0	10.6	0.4	5.5	1.6	5.2	6.0	0.2	1.7	3.2	6.5	0.3	4.6	0.2	0.6	4.8	3.2	2.9	3.6	1.6	5.7	2.1	2.0	1.6	2.8	2.7	0.9	0.0	2.4	2.2	1.0	0.2	0.2	1.2	2.5	2.7	1.2	10.4	0.0	11.8	13.3	3.6	1.6	0.3	10.3	0.0	8.3	11.5	1.1	0.5	5.7	22.2	10.2	1.6	0.0	0.0	2.7	3.8	0.3	1.7	0.0	1.8	2.7	0.5	4.8	2.9	0.4	51.8	0.5	0.0	0.9	2.7	14.3	0.3	3.8	4.4	2.8	1.1
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 185.5;Hepatocytes: 244.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 35.3;RT4: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes		NA	NA		160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favorable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.4	7.7	2.5	3.8	13.3	5.6	35.3	4.0	4.0	4.8	5.5	5.4	9.0	3.1	4.3	6.8	4.5	3.3	10.7	4.2	7.6	2.8	3.2	4.0	4.4	17.7	7.2	3.4	2.6	9.3	3.3	5.4	3.6	5.1	12.0	4.3	4.1	3.1	5.3	16.1	7.6	2.5	1.9	13.5	6.7	4.2	7.7	3.6	8.1	47.5	3.1	4.6	11.4	17.8	3.8	8.7	10.9	3.9	7.9	6.7	4.9	5.4	3.8	5.1	3.5	1.2	3.9	3.2	3.9	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3	26.8	20.6	3.0	13.1	11.9	23.8	38.6	48.4	14.7	18.2	22.7	21.6	32.5	18.3	19.8	8.4	14.6	185.5	23.3	35.6	39.3	17.0	27.2	16.2	244.8	23.1	17.5	33.1	22.1	31.8	6.5	27.6	19.9	13.5	25.2	35.0	64.2	31.5	87.7	44.2	74.6	28.4	0.0	16.4	5.6	10.7	26.5	36.2	10.2	32.4	22.6
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 359.4;Hepatocytes: 1018.8;Late spermatids: 335.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.2;ASC TERT1: 36.7;HSkMC: 80.3;RPTEC TERT1: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Nucleoplasm	"Mitochondria, Cytosol"	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	6.1	1.9	1.2	3.1	151.2	36.7	1.0	3.4	1.7	2.0	1.4	0.4	1.7	2.5	0.3	4.0	4.9	3.8	5.4	2.2	1.7	12.4	1.9	1.8	1.7	5.0	24.3	4.9	4.6	80.3	18.6	1.7	8.7	3.6	2.6	0.4	0.8	7.8	9.8	3.2	0.3	6.8	0.2	4.1	2.7	0.9	1.0	3.2	47.8	17.5	4.6	4.3	3.1	9.4	10.5	0.5	3.4	5.0	2.8	1.8	2.1	4.3	1.0	3.0	1.5	1.1	5.8	6.9	2.8	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9	23.8	107.2	14.5	16.5	18.7	5.8	89.7	28.1	13.4	21.6	29.6	17.7	8.6	79.6	3.9	359.4	5.6	2.6	0.0	11.0	1.9	9.1	56.1	23.1	1018.8	39.4	3.2	0.0	19.0	136.2	335.5	17.8	64.1	30.4	24.4	4.2	3.3	9.0	0.9	15.6	75.0	10.3	12.9	12.0	8.1	16.7	35.9	2.9	10.0	1.7	21.4
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 59.8;U-266/84: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.1	6.6	3.7	4.8	2.6	4.1	6.4	5.5	4.1	2.5	1.9	21.6	5.0	1.3	2.9	7.8	9.7	1.9	0.9	4.0	2.6	4.1	3.5	3.1	4.8	6.2	1.8	1.9	1.0	6.2	2.0	3.3	1.2	3.6	2.8	2.7	1.2	4.9	7.5	3.0	1.6	2.4	3.3	3.0	10.8	1.9	6.3	2.1	11.3	20.7	2.1	2.9	9.1	6.5	5.5	3.2	5.0	1.9	5.2	8.4	1.9	2.1	4.4	59.8	31.1	2.4	2.4	3.9	6.2	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1	3.0	2.6	0.0	0.4	0.3	3.3	0.9	7.6	4.0	5.7	1.8	0.0	0.9	5.0	0.7	8.1	0.8	5.0	0.0	3.3	0.9	1.1	0.6	0.0	17.8	0.9	4.8	4.1	1.3	1.2	18.9	0.6	0.8	0.0	1.8	4.5	10.6	2.4	3.5	2.1	33.2	0.8	0.0	0.5	0.7	0.7	0.5	0.2	0.8	4.0	0.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 649.9"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	85.8	44.1	0.0	1.4	2.6	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.5	0.0	0.0	3.9	4.8	0.0	0.1	0.0	1.0	4.3	5.7	0.2	0.0	17.7	1.0	5.6	17.7	1.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	6.8	3.0	2.4	0.0	0.5	0.0	0.0	0.6	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2	3.0	0.6	13.7	0.5	1.5	0.0	0.7	12.7	0.0	0.0	3.5	0.0	0.0	10.0	0.6	0.5	1.3	0.0	0.0	22.4	0.1	10.2	8.3	0.0	649.9	0.4	0.0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0.0	0.0	0.4	18.4	0.0	77.1	111.5	0.0	0.0	2.8	0.7	0.6	1.4	0.0	0.0	0.0	0.3
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843538-40850447	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	165	"liver: 199.5"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 161.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	199.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.1	5.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	161.7	0.0	0.0	0.0	12.9	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 113.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4"														"Intracellular and membrane"	NA	NA						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	4.4	0.0	0.0	0.0	0.9	0.5	0.2	0.3	0.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	3.5	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	14.7	0.0	6.4	0.1	0.0	0.0	0.0	113.1	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.3	0.0	1.5	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell type enriched"	"Detected in single"	31	"Hepatocytes: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"									HPA015066	Supported				"Intracellular and membrane"	NA	NA					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 1616.5"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	2.3	1.2	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	21.0	0.0	0.0	0.9	0.2	155.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	70.0	0.2	0.0	0.0	0.1	0.0	1616.5	0.0	4.8	1.7	61.4	65.7	5.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.1
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94989391	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 233.0"	"Cell type enriched"	"Detected in some"	48	"Hepatocytes: 1765.4"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6"									"HPA015066, CAB016123"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016123: AB_629363, HPA015066: AB_1847433"	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	45.8	0.0	0.0	13.6	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.5	233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	43.8	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.4	0.9	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.1	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	0.0	4.2	23.3	0.6	0.0	0.0	0.0	0.0	1765.4	0.0	0.0	0.0	36.8	31.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 78.0"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 435.9"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3"									HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	78.0	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.3	0.2	0.0	0.6	0.0	0.2	3.6	0.0	1.1	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.3	4.3	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.5	0.5	6.5	0.3	2.5	1.4	0.0	1.8	2.0	0.1	1.7	0.6	2.9	0.3	3.9	0.0	0.5	0.1	0.2	0.5	0.0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0.0	0.0	0.0	0.0	1.0	0.9	0.5	2.9	1.4	0.5	2.0	0.0	0.2	0.7	0.3	1.0	0.3	0.5	0.8	0.2
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell type enriched"	"Detected in some"	45	"Hepatocytes: 2276.5"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.1	4.5	0.3	0.0	0.0	0.0	2.2	6.7	0.0	0.5	2.6	5.0	0.5	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.4	0.0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.3	1.0	0.3	0.0	0.3	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.6	46.7	0.8	0.0	0.0	0.5	0.0	2276.5	0.0	0.0	0.0	39.3	50.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.9
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	2.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	8.3	5.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.3	0.2	23.6	0.0	0.1	0.0	0.6	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4	11.9	11.3	11.2	107.3	41.0	13.1	1.0	346.5	14.7	12.5	3.5	11.8	1.3	0.0	58.0	1.7	2.5	640.5	46.7	44.6	1.0	3.8	166.5	9.3	330.1	0.6	7.9	52.5	9.8	8.3	0.0	2.3	4.6	3.3	7.2	117.1	6.0	69.5	210.5	2.5	4.2	20.2	0.0	3.5	6.8	4.2	51.6	1.3	12.9	85.2	352.8
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 132.0"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 9.0"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"	NA	NA					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	9.0	0.0	1.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	1.6	0.1	0.0	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.9	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	6.2	0.0	16.2	0.0	0.3	0.0	0.0	0.6	0.0	132.0	0.0	0.0	1.7	0.6	3.9	11.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	5.8	0.0	14.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.0	0.1
CYP4F3	"CYP4F, LTB4H"	ENSG00000186529	"Cytochrome P450 family 4 subfamily F member 3"	Q08477	19	15640897-15662825	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 159.2"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 506.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 30.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	68	"neutrophil: 33.1"	"Lineage enriched"	"Detected in single"	166	"granulocytes: 33.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.73e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.40e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.07e-1)"	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0.0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0.0	0.4	1.9	0.1	0.2	0.0	0.2	0.0	1.6	0.3	0.5	0.0	1.3	0.1	0.1	1.2	13.4	0.1	1.0	2.6	1.7	0.2	1.8	0.0	0.1	1.1	0.8	1.8	2.7	0.0	0.0	33.1	0.1	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	20.0	0.0	0.1	0.0	0.0	9.1	0.0	0.1	0.0	0.3	0.0	0.1	1.9	10.9	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8	8.9	5.9	5.1	2.3	0.9	0.0	0.8	91.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	13.5	23.3	0.2	0.1	0.3	1.7	1.1	506.3	0.0	0.0	50.9	6.2	10.2	0.4	0.0	0.4	0.0	0.0	5.6	0.0	2.5	7.0	0.0	31.2	0.0	0.0	0.2	0.0	0.1	5.6	0.0	0.8	8.3	10.8
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 227.5;Proximal tubular cells: 124.0"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA					"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.3	3.5	1.0	0.0	5.3	4.5	1.1	4.0	1.2	2.6	3.0	15.2	5.3	0.0	15.9	4.0	1.0	4.1	0.0	3.3	5.5	11.1	3.7	5.9	0.9	15.4	3.5	0.7	0.1	6.4	4.3	2.7	2.4	3.6	3.8	0.0	3.8	4.3	5.0	4.3	0.1	3.5	2.1	3.0	4.4	0.0	7.1	0.3	11.0	4.7	3.2	4.6	7.8	4.6	7.3	9.1	16.8	6.9	1.8	1.7	2.6	1.3	0.3	1.2	3.8	0.3	0.6	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9	14.9	7.5	13.7	1.5	1.3	0.2	17.9	25.5	4.0	4.5	19.2	3.9	7.2	16.6	2.0	0.1	2.8	13.8	0.0	5.9	2.1	1.5	1.8	0.0	227.5	3.7	0.0	7.5	12.3	12.4	0.0	0.6	1.3	3.3	15.4	11.6	1.7	3.3	8.6	0.4	124.0	0.9	0.0	2.0	3.9	4.1	0.4	1.1	3.2	10.6	1.6
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		48000	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	17.0	6.6	6.5	14.5	22.1	13.2	9.4	5.4	15.1	11.9	11.0	9.5	17.6	7.8	8.5	6.9	6.2	6.9	4.2	6.5	7.1	7.3	8.5	10.6	10.0	6.4	10.8	22.7	17.7	9.1	7.0	6.9	9.0	14.2	10.4	4.5	16.1	56.5	7.7	12.4	8.3	24.4	4.3	26.0	5.5	8.6	15.0	44.2	7.5	10.3	9.5	8.4	14.5	33.9	18.9	7.6	18.9	22.6	7.3	14.6	13.2	5.5	13.5	32.1	38.5	13.1	10.9	30.2	17.7	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8	47.6	56.2	18.6	26.4	16.0	13.7	8.3	25.5	48.2	37.5	27.9	7.9	72.3	5.0	32.4	47.6	31.3	41.1	23.3	26.7	48.8	48.3	25.5	35.8	64.7	114.3	15.9	41.2	39.9	74.2	36.8	40.0	72.1	37.1	43.3	42.3	27.3	25.9	48.9	26.9	19.2	17.7	25.8	22.6	41.3	28.8	12.9	56.0	34.6	40.6	25.3
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HADHB	MTPB	ENSG00000138029	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta"	P55084	2	26243170-26290468	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.0;skeletal muscle: 155.6"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 922.0;Distal tubular cells: 441.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037539, HPA037540, HPA066099"	Enhanced		Supported	Mitochondria		No	No		1100000	Mitochondria		"HPA037539: AB_10671374, HPA037540: AB_2675531, HPA066099: AB_2685618"	"unprognostic (5.15e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.21e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-2)"	"unprognostic (7.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (1.37e-9)"	"unprognostic (2.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.68e-2)"	23.3	45.5	24.8	11.0	24.7	9.9	16.6	16.6	17.4	13.8	21.4	31.1	19.3	43.6	17.1	16.2	20.6	13.9	12.6	126.0	18.0	20.0	45.8	62.4	12.8	16.1	34.8	18.3	16.2	23.7	19.9	13.1	12.6	27.8	15.8	22.8	19.9	27.2	15.9	155.6	13.2	35.0	20.3	29.5	15.3	19.5	15.8	23.8	10.6	22.4	44.9	14.5	18.5	12.8	20.2	45.2	21.5	49.1	23.8	26.8	33.9	23.1	18.3	12.8	22.9	79.0	43.7	13.0	19.5	29.9	20.1	19.7	21.8	22.6	11.6	13.7	31.9	22.6	18.3	21.2	27.6	24.7	26.1	18.5	26.6	10.9	42.7	33.9	21.5	20.4	42.3	45.5	20.9	34.0	34.3	37.2	18.0	22.3	18.8	41.9	17.0	12.0	41.5	8.9	34.8	19.9	13.3	42.2	22.0	41.3	32.9	6.1	21.1	33.4	38.1	51.2	16.0	23.6	38.4	25.7	19.0	19.9	17.8	14.0	14.1	21.2	20.4	21.8	34.3	18.8	21.0	49.1	18.9	14.2	43.4	18.1	20.2	19.3	17.6	45.2	14.8	18.0	16.3	21.5	23.8	33.2	15.3	26.8	33.9	24.8	24.7	16.6	17.4	18.0	20.0	34.8	18.3	27.8	23.8	44.7	32.2	48.9	103.6	55.2	29.0	922.0	127.4	46.8	42.1	92.5	53.0	177.3	441.0	96.4	60.4	68.1	196.9	116.8	50.2	61.8	59.6	61.5	62.2	218.5	127.1	12.7	71.9	67.5	100.7	74.5	52.3	80.0	84.4	77.5	85.7	52.4	56.5	91.7	59.1	244.7	72.5	71.1	92.4	75.6	46.1	47.8	156.1	48.0	100.9	85.2
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.8	15.4	29.0	38.4	72.4	34.0	15.3	17.4	23.5	16.5	30.1	12.7	29.8	23.9	35.9	18.8	24.3	18.0	21.3	37.9	25.8	26.1	19.7	31.4	16.8	24.2	18.4	9.9	49.2	29.6	15.9	17.7	16.7	19.4	28.2	16.5	10.7	13.9	17.9	15.5	15.1	6.4	21.5	44.1	10.9	19.3	29.1	25.8	26.4	49.4	21.9	18.9	40.9	6.4	19.0	28.7	23.7	16.7	20.0	16.2	11.1	17.8	14.2	7.1	14.8	8.8	18.4	26.5	15.9	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5	68.5	94.4	20.8	34.3	13.3	18.5	62.9	81.5	24.1	47.8	34.9	13.7	57.8	71.3	28.8	7.4	26.4	50.3	0.0	31.4	21.8	24.2	32.2	65.9	203.2	70.1	14.3	31.7	31.3	50.9	9.3	31.9	35.3	8.5	103.6	42.6	44.1	23.2	24.6	48.1	50.5	15.4	6.5	20.0	15.9	22.2	15.1	54.3	13.1	51.1	31.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 460.4"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	12.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6.0	32.1	1.4	0.7	0.8	0.0	0.3	25.5	8.1	14.8	3.5	0.0	1.5	1.7	0.2	9.0	0.5	4.0	0.0	1.8	1.9	2.6	2.2	0.0	460.4	0.2	0.0	0.0	8.6	7.0	3.6	7.5	0.0	13.5	0.0	2.3	3.0	1.5	0.0	2.8	5.2	0.0	0.0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984983	"FDA approved drug targets, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 94.2"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 213.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA					"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.2	0.2	0.8	0.2	1.3	0.2	0.2	0.4	1.4	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	1.8	94.2	0.2	0.2	0.2	2.4	0.6	0.2	0.2	0.2	0.1	0.2	4.1	0.2	0.2	9.4	0.2	0.2	0.2	0.2	0.2	0.2	2.4	0.2	0.2	0.2	0.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	1.4	0.8	1.8	2.4	0.6	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 88.9"	"Group enriched"	"Detected in some"	16	"Hepatocytes: 185.6;Proximal tubular cells: 86.1"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enriched"	"Detected in single"	19	"Hep G2: 14.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA					"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	88.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.3	2.5	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.6	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.1	0.4	0.1	1.8	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	7.6	1.4	0.0	7.0	0.0	0.4	10.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	34.1	40.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	88.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252230-45277845	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"gallbladder: 28.7;intestine: 49.3"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 26.0;Paneth cells: 17.3;Undifferentiated cells: 59.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;NB-4: 2.3"					"Low region specificity"	"Detected in all"			"HPA046068, HPA055623"	Enhanced					NA	NA					"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.8	18.5	0.2	0.1	25.7	0.4	0.1	0.3	0.2	28.7	0.1	0.2	0.2	1.0	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	1.6	0.1	0.2	13.8	0.1	0.1	0.1	0.1	0.2	49.3	0.1	0.2	0.1	8.5	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.6	0.2	1.3	0.5	0.6	0.7	0.0	0.1	0.3	0.1	0.1	0.0	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.5	0.6	0.2	0.0	0.0	0.7	0.0	0.1	0.2	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	1.5	0.0	0.1	0.3	2.3	0.2	0.9	0.3	0.2	0.4	1.3	0.0	0.2	1.1	1.6	0.0	0.1	0.3	0.6	0.2	0.6	0.3	0.4	0.5	1.2	0.2	0.8	0.2	0.3	0.4	0.6	0.3	1.3	0.2	0.1	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.6	0.4	0.7	0.2	0.6	0.5	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	7.2	0.9	0.2	0.1	2.7	0.4	12.7	8.1	7.9	0.0	2.0	11.0	0.0	0.0	0.4	0.4	26.0	0.0	0.0	1.6	0.4	0.2	8.1	0.0	0.8	1.6	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.5	0.0	17.3	0.7	0.3	4.6	0.0	0.0	1.9	1.7	0.3	3.9	0.9	59.6	0.1
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 7.6;Ductal cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA					"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.9	0.0	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.5	0.0	0.1	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.7	7.6	4.0	1.2	1.8	0.0	0.1	0.0	17.3	1.0	0.0	0.3	0.0	2.6	0.1	0.1	0.1	1.1	0.0	1.9	0.0	2.9	0.0	2.4	1.3	0.0	0.7	0.0	1.8	3.4	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.0	2.4	0.1
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell type enriched"	"Detected in some"	9	"Alveolar cells type 1: 32.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0"					"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.0	0.5	0.8	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	2.9	1.7	0.1	2.1	0.1	0.0	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.4	1.1	0.0	0.3	0.2	0.0	1.3	0.1	0.1	1.2	0.1	0.4	3.4	1.4	0.0	2.0	0.3	0.1	13.3	1.5	0.1	0.1	0.2	9.2	0.0	2.0	1.8	2.3	0.0	0.2	0.2	14.2	2.6	0.7	0.0	0.0	1.4	0.6	0.3	19.8	8.0	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4	32.8	1.9	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	1.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131202-21239246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	618	"liver: 121.0"	"Cell type enriched"	"Detected in some"	39	"Hepatocytes: 71.0"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6"									HPA050892	Supported					NA	NA					"HPA050892: AB_2681265"			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.8	0.0	0.4	0.0	0.8	0.0	0.0	1.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.1"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 171.3;Hofbauer cells: 103.0;Kupffer cells: 116.2;Macrophages: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;GAMG: 8.9;Hep G2: 8.1;HMC-1: 10.9;OE19: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA					"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	21.4	15.2	15.0	13.4	23.1	1.4	7.8	4.8	15.8	8.6	12.9	22.8	0.8	18.0	5.8	7.7	8.8	8.3	12.3	7.1	15.6	11.9	9.6	98.1	24.9	21.4	23.9	7.4	4.9	9.6	3.7	4.0	18.3	17.7	4.9	10.4	9.1	6.3	4.7	2.6	3.0	21.2	10.9	24.1	23.6	6.5	4.4	21.3	4.0	6.8	3.6	11.8	12.5	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.3	8.1	0.0	0.4	10.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	3.6	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	23.1	4.8	15.8	15.6	11.9	23.9	7.4	17.7	21.3	0.0	12.8	1.5	0.0	1.6	1.6	2.0	20.4	1.4	3.4	0.0	0.0	0.6	1.7	0.0	2.4	12.9	20.2	0.0	0.2	2.1	1.8	0.0	23.0	171.3	103.0	0.0	0.0	3.1	116.2	1.1	10.0	55.1	0.0	3.6	4.4	0.3	0.1	14.0	9.9	7.0	0.2	0.0	0.3	0.5	0.2	0.4	2.1	0.7	9.3	0.0
SULT1A1	"P-PST, STP, STP1"	ENSG00000196502	"Sulfotransferase family 1A member 1"	P50225	16	28605196-28623625	"Enzymes, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 529.7;Hepatocytes: 206.6;Paneth cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 50.6;intermediate monocyte: 39.2;myeloid DC: 22.9;neutrophil: 47.7;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	26	"dendritic cells: 22.9;granulocytes: 47.7;monocytes: 50.6"	"Group enriched"	"Detected in many"	4	"EFO-21: 42.4;Hep G2: 83.9"									"HPA049500, HPA051051"	Supported					NA	NA		3700000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.10e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.89e-2)"	10.2	36.1	12.0	7.2	15.4	9.3	5.7	15.8	19.8	4.6	21.4	4.5	15.5	54.2	3.7	14.4	3.1	6.6	5.4	9.7	14.7	10.4	11.0	98.1	26.7	8.4	9.2	14.9	3.5	9.6	6.7	10.0	5.6	10.3	3.7	17.5	12.2	11.5	22.5	4.9	1.4	41.1	5.2	6.3	23.2	7.2	5.1	4.6	4.0	13.4	2.6	3.7	6.3	2.2	0.3	22.9	47.7	50.6	0.9	1.5	19.3	1.6	0.6	0.8	2.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	10.5	0.2	42.4	0.0	0.4	0.6	0.8	2.9	0.1	0.3	7.5	2.8	3.2	83.9	5.0	0.0	3.2	0.2	0.2	0.1	0.0	0.1	0.8	3.2	1.1	1.4	0.8	9.9	0.2	2.2	0.7	0.4	0.0	3.1	0.3	5.5	0.7	0.9	2.6	0.2	0.7	13.8	0.3	3.9	8.2	8.1	5.5	0.2	2.1	0.2	0.1	3.3	1.9	0.4	0.7	15.5	0.0	4.9	50.6	0.9	0.6	39.2	0.7	0.3	0.6	0.5	22.9	0.1	0.9	0.6	47.7	0.9	22.3	1.7	1.5	19.3	12.0	15.4	15.8	19.8	14.7	10.4	9.2	14.9	10.3	4.6	178.6	77.7	8.2	7.0	1.0	16.8	12.3	43.3	46.8	22.7	15.7	9.8	2.0	109.5	9.9	94.0	8.0	529.7	0.0	18.0	1.1	16.2	2.7	47.5	206.6	32.1	7.9	19.1	43.0	192.8	26.4	47.5	39.4	1.7	16.2	39.6	65.5	6.2	294.5	32.5	16.8	3.5	19.4	9.9	20.2	4.5	0.3	1.6	7.5	70.4	5.8
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 83.9"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;OE19: 35.4;RT4: 19.3"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.1	0.2	0.1	1.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.3	35.4	3.6	0.0	0.1	0.3	0.0	19.3	0.1	0.2	1.4	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.7	6.8	1.8	0.0	0.0	0.0	0.2	2.8	0.0	3.5	0.0	0.0	0.0	0.0	0.9	0.0	83.9	0.0	0.0	0.0	1.3	3.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	6.2
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell type enhanced"	"Detected in some"	22	"Club cells: 1.2;Enterocytes: 2.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	142	"RT4: 109.0"														"Intracellular and membrane"	NA	NA								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 40.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 16.7"															NA	NA												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Group enriched"	"Detected in some"	8	"Club cells: 4.5;Hepatocytes: 10.5"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2"															NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 37.7;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 40.4;OE19: 160.5"									"CAB009819, HPA054065"	Enhanced					NA	NA					"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	11.3	0.0	0.1	40.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	160.5	0.0	0.0	0.0	0.0	0.4	20.4	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.3	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	37.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.6	0.0	19.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	2.1
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 8.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	14	"SiHa: 50.6"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	50.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	8.4
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 13.0;urinary bladder: 15.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	58	"RT4: 52.5"															NA	NA								"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0		4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.3	0.0	0.0	0.0	0.0	0.0	3.3	5.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Cell type enhanced"	"Detected in some"	29	"Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"A549: 4.9;RT4: 4.0"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	5.2	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 539.4;Proximal tubular cells: 775.7"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 21.0;RPTEC TERT1: 83.6"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	83.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	3.9	0.6	0.1	0.0	0.0	58.6	0.0	0.0	118.7	0.0	0.0	82.9	5.6	0.2	0.0	6.7	0.0	9.1	0.0	0.0	0.4	0.0	539.4	0.1	0.0	3.4	6.2	10.7	0.0	1.7	0.0	3.3	0.0	20.1	0.0	11.8	11.9	0.0	775.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	2.0
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Group enriched"	"Detected in many"	5	"Enterocytes: 95.3;Hepatocytes: 35.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 6.2;HBEC3-KT: 15.3;hTERT-HME1: 24.5;U-251 MG: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	No	No			Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.2	3.6	0.7	1.1	0.2	1.7	0.0	1.2	0.2	0.6	3.2	0.0	15.3	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.9	24.5	0.3	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.9	0.1	0.0	1.1	3.3	4.5	3.9	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	3.0	1.9	0.1	6.7	2.0	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0	0.0	3.7	0.0	2.6	0.5	0.3	0.3	2.5	0.0	2.3	0.0	0.0	0.1	0.0	2.4	0.2	0.0	95.3	0.0	7.2	0.5	0.0	0.5	0.0	35.8	0.0	0.0	11.3	1.8	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.1	8.8	7.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.1	0.3	0.0	12.8	14.2
